What Sustained Audit Pressure Is Doing to Wound Care

A provider in Macon, Georgia recently reached out while trying to work through a case that should have been straightforward. The patient needed treatment, but the support around the case had started to give way. His representative was no longer available, calls were not being returned, and payment behavior had shifted without a clear explanation.

He was left trying to make a treatment decision without support and without much confidence in how that decision would hold up later.

That situation is becoming more common. Over the past year, many practices have seen support structures thin out at the same time expectations around documentation and review have tightened. More of the coordination that used to be shared across reps, support teams, and manufacturers now falls directly on the practice.

That is part of what has changed in wound care. Audit pressure has been present for years, but it is now showing up more consistently across practices and more directly inside treatment decisions. Practices in different regions are dealing with the same pattern at the same time, as enforcement activity expands alongside broader efforts to recover improper payments and tighten control over higher-cost categories.

A separate case out of Jacksonville shows a different side of the same issue. A physician is currently working through audits across 47 dates of service, with additional reviews initiated on the same patient before the first set was resolved.

During that period, a patient with a large venous wound presented for care. Conservative treatment was followed for several months. When it came time to move into advanced therapy, the physician chose not to proceed.

The decision was not based on eligibility. It was all about exposure.

What Is Driving It

From a policy standpoint, the increase in audit activity is not unexpected. Wound care has drawn attention due to rapid spending growth, variability in documentation, and concerns around improper payments. Compliance guidance continues to point to medical necessity, documentation, and utilization patterns as areas that trigger review.

At the same time, enforcement efforts have expanded in categories considered high risk, with a greater focus on identifying and recovering payments.

That pressure does not stay confined to retrospective review. It carries forward into how physicians approach cases in real time, particularly when there is uncertainty around how decisions will be interpreted later.

Audit defense costs alone can run into the thousands per note, before accounting for the time and operational effort required to respond. That level of exposure becomes part of how cases are evaluated before treatment even begins.

Where This Leads

Some providers are becoming more selective in how they use advanced therapies, while others are reducing volume or stepping away from certain cases altogether. The clinical rationale has not changed as much as the conditions surrounding these decisions, and when expectations are difficult to interpret and the cost of being wrong is high, caution begins to shape which cases move forward.

Audit activity is often framed as a correction mechanism, focused on improper billing or system abuse. Those elements are part of the picture, but they do not fully explain what happens when sustained pressure reaches providers who are trying to operate correctly. When standards are applied inconsistently or after the fact, more time is spent building a case that can be defended, not just delivering care.

That shift carries a cost—in time, in operational burden, and in terms of a physician’s choice to move forward with treatment at all.

This is where Bionavix is focused—helping practices interpret how audit pressure is actually being applied, working through case strategy in advance, and staying present in an environment where many support structures have thinned out.

Providers who adjust how they operate within this environment will be better positioned as expectations continue to take shape.